AACR IO 2026 Keynote Highlights: Cancer Vaccines Are Here, and Upgrading T Cells To Thrive in the Tumor Microenvironment
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Although not as common as breast, prostate, or lung cancer, kidney cancer is one of the most frequently diagnosed...
The milieu of cells, proteins, and vasculature that comprise the tumor microenvironment can hinder efforts to treat cancer. This...
The numbers are in, and AACR Annual Meeting 2023 was a resounding success. From April 14-19, more than 20,000...
The concept of using vaccination to eradicate cancer by instructing the immune system to eliminate malignant cells has been...
A study that examined the catchment areas of 102 cancer centers in the U.S. found that while over a...
Editor’s note: As we honor National Cancer Survivor Month, we are also recognizing the AACR Scientist↔Survivor Program’s positive impact...
Another month brings another round of Editors’ Picks! As we picked our May flowers, the editors picked their favorite...
“It is more important to know what sort of person has a disease than to know what sort of...
The American Association for Cancer Research (AACR) was thrilled to welcome Super Bowl Champion Rodney McLeod Jr. and Erika...
“Where is the field of cancer research going?” posed Robert Vonderheide, MD, DPhil, as he welcomed attendees to “AACR...